Table 3 |
||||
|
Characteristics and outcomes of individuals classified as No metabolic syndrome, At-risk-for metabolic syndrome, and with Metabolic syndrome using individuals with all five criteria measured* |
||||
|
No metabolic syndrome* |
At-risk-for metabolic syndrome* |
Metabolic syndrome* |
||
|
0 criteria |
1-2 criteria |
3 or more |
||
|
|
||||
|
Baseline characteristics |
||||
|
|
||||
|
N = 30,461 |
9,529 |
16,674 |
4,258 |
|
|
Age, years (SD) |
45 (14) |
51 (15) |
52 (14) |
|
|
Women, % |
65.8% |
59.9% |
51.2% |
|
|
Race (% White) |
76.9% |
76.0% |
78.1% |
|
|
Insurance (% Commercial) |
80.2% |
66.4% |
61.2% |
|
|
Income, $US (SD) |
$80,859 ($60,623) |
$69,846 ($54,333) |
$61,086 ($45,290) |
|
|
|
||||
|
Three-year outcomes |
p-value † |
|||
|
|
||||
|
Inpatient admissions, mean number per patient (SD) |
0.10 (0.52) |
0.23 (1.07) |
0.36 (1.25) |
<.0001 |
|
Length of stay, mean days (SD) § |
4 (3) |
6 (3) |
6 (3) |
<.0001 |
|
Outpatient clinic visits, mean number per patient (SD) § |
4.3 (2.2) |
7.2 (2.5) |
11.0 (2.4) |
<.0001 |
|
Total cost, US dollars (SD) § |
$3,804 ($4) |
$4,665 ($4) |
$5,271 ($4) |
<.0001 |
|
Incidence of diabetes mellitus |
1.1% |
3.7% |
11.0% |
<.0001 |
|
Incidence of CHD |
2.1% |
4.7% |
6.5% |
<.0001 |
|
|
||||
|
*patients categorized after excluding patients with diabetes and/or CHD, having all five criteria measured (formal or surrogate); prevalence of each risk factor were 40.8% for obesity, 35.6% for blood pressure, 25.1% for HDL, 18.6% for triglycerides, and 6.7% for glycemia. † p-values for trend in age-sex-adjusted regression analysis in all three categories of metabolic syndrome status §log-transformed for analysis and then back-transformed for display |
||||
|
Hivert et al. BMC Health Services Research 2009 9:170 doi:10.1186/1472-6963-9-170 |
||||
